SOM3355 is still an investigational drug, and only a Phase 3 trial can determine whether it is safe and effective enough to seek approval. But the combined momentum from the EMA and FDA reflects a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback